1. Hughes RA. Peripheral neuropathy. BMJ. 2002; 324:466–469.
2. Barohn RJ, Amato AA. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin. 2013; 31:343–361.
Article
3. Javed S, Petropoulos IN, Alam U, Malik RA. Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 2015; 6:15–28.
Article
4. Kanji JN, Anglin RE, Hunt DL, Panju A. Does this patient with diabetes have large-fiber peripheral neuropathy? JAMA. 2010; 303:1526–1532.
Article
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 1995; 122:561–568.
6. Griebeler ML, Morey-Vargas OL, Brito JP, Tsapas A, Wang Z, Carranza Leon BG, et al. Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med. 2014; 161:639–649.
Article
7. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011; 76:1758–1765.
Article
8. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004; 63:865–873.
Article
9. Wiktorsson-Moller M, Oberg B, Ekstrand J, Gillquist J. Effects of warming up, massage, and stretching on range of motion and muscle strength in the lower extremity. Am J Sports Med. 1983; 11:249–252.
Article
10. Said G. Vasculitic neuropathy. Curr Opin Neurol. 1999; 12:627–629.
Article
11. Hawke SH, Davies L, Pamphlett R, Guo YP, Pollard JD, McLeod JG. Vasculitic neuropathy. A clinical and pathological study. Brain. 1991; 114(Pt 5):2175–2190.
12. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005; 252:633–641.
Article
13. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993; 33:4–9.
Article
14. Said G, Lacroix-Ciaudo C, Fujimura H, Blas C, Faux N. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol. 1988; 23:461–465.
Article
15. Mawdsley C, Mayer RF. Nerve conduction in alcoholic polyneuropathy. Brain. 1965; 88:335–356.
Article
16. Vittadini G, Buonocore M, Colli G, Terzi M, Fonte R, Biscaldi G. Alcoholic polyneuropathy: a clinical and epidemiological study. Alcohol Alcohol. 2001; 36:393–400.
Article
17. Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol. 2006; 19:481–486.
Article
18. Shields RW Jr. Alcoholic polyneuropathy. Muscle Nerve. 1985; 8:183–187.
Article
19. McCombe PA, McLeod JG. The peripheral neuropathy of vitamin B12 deficiency. J Neurol Sci. 1984; 66:117–126.
Article
20. Rizzo G, Lagana AS, Rapisarda AM, La Ferrera GM, Buscema M, Rossetti P, et al. Vitamin B12 among Vegetarians: Status, Assessment and Supplementation. Nutrients. 2016; 8.
Article
21. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurology. 2006; 5:949–960.
Article
22. Vilholm OJ, Christensen AA, Zedan AH, Itani M. Drug-induced peripheral neuropathy. Basic Clin Pharmacol Toxicol. 2014; 115:185–192.
Article
23. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008; 13:27–46.
Article